Skip to main content
. 2018 Aug 17;9(3):287–297. doi: 10.1007/s13167-018-0147-5

Table 4.

Discrimination performance of discriminative LMI pairs (PC/BTC versus PC/BTC HRG)

Mass value (m/z) Retention time (min) Mass value (m/z) Retention time (min) Sensitivity Specificity
Numerator LMI Denominator LMI
756.3643 10.02 657.6682 10.32 94.44% 91.67%
380.7359 7.03 181.0714 7.73 90.74% 91.67%
381.7330 6.94 181.0714 7.73 90.74% 91.67%
712.9321 8.55 657.6682 10.32 90.74% 91.67%
756.5703 10.01 657.6682 10.32 90.74% 91.67%
Minuend LMI Subtrahend LMI
630.3031 10.01 657.6682 10.32 92.59% 91.67%
756.1579 9.99 657.6682 10.32 92.59% 91.67%
756.3643 10.02 657.6682 10.32 92.59% 91.67%
380.7359 7.03 181.0714 7.73 90.74% 91.67%
381.7330 6.94 181.0714 7.73 90.74% 91.67%
712.9321 8.55 657.6682 10.32 90.74% 91.67%
756.1579 9.99 657.3503 10.33 90.74% 91.67%
756.5703 10.01 657.6682 10.32 90.74% 91.67%

LMI low-mass ion, PC pancreatic cancer, BTC biliary tract cancer, HRG high risk group